Mutations in ATM (ataxia-telangiectasia mutated) cause Ataxia-Telangiectasia (AT), a disease characterized by neurodegeneration, sterility, immunodeficiency, and T cell leukemia. Defective ATM-mediated DNA damage responses underlie many aspects of the AT syndrome, but the basis for the immune deficiency has not been defined. ATM associates with DNA double-strand breaks (DSB), and some evidence suggests that ATM may regulate V(D)J recombination. 
Introduction
AT is an autosomal recessive disease with a pleiotropic phenotype that includes cerebellar degeneration, immunodeficiency, sterility, radiosensitivity, and an elevated incidence of lymphoid malignancies 1 . AT is caused by mutations in ATM, a gene belonging to the phosphatidylinositol 3-kinase (PI3-K) related family of serine-threonine kinases that function in DNA damage surveillance and repair 2 . The radiosensitivity and increased cancer susceptibility of AT patients and Atm -/-mice are thought to reflect loss of these ATM-dependent DNA damage responses 2 , whereas defective DNA repair by homologous recombination likely underlies the sterility of AT patients [3] [4] [5] . However, the cause of AT-related immune deficiency has not been defined. AT patients are variably lymphopenic and display a range of cellular and humoral immunological abnormalities 6 , leading to recurrent and sometimes fatal sinopulmonary infections. In particular, AT patients exhibit low output of mature TCR hi CD4 and CD8 single positive (SP) thymocytes, and their peripheral T cell pool often exhibits oligoclonal TCR Vβ expansions and abnormally low naïve/memory T cell ratios 7 . Like AT patients, Atm-deficient mice also have decreased numbers of mature thymocytes and peripheral T cells, suggesting defective intrathymic T cell development [8] [9] [10] [11] . Given ATM's prominent role in regulating DNA damage responses, much interest has focused on the possibility that ATM has critical functions in V(D)J recombination, the somatic rearrangement process by which developing T and B lymphocytes generate a diverse repertoire of antigen receptor variable (V) genes. TCRβ and TCRα recombination occur sequentially during the successive CD4/CD8 double negative (DN) and CD4/CD8 double positive (DP) stages of T cell development, respectively. Signaling through TCRβ-containing pre-TCR complexes is required to generate a large pool of DP thymoctyes from DN precursors. TCRα rearrangement begins in post-mitotic DP thymocytes 12 . However, the TCRα locus can undergo successive rounds of secondary recombination to maximize the opportunity for DP to produce a TCRαβ heterodimer that can induce positive selection in response to self major histocompatibility complex proteins [13] [14] [15] . Thus, failure to make successful (in-frame) TCRβ rearrangements arrests T cell development at the DN stage, whereas failure to produce an appropriate (selectable) TCRα rearrangement arrests development at the DP stage. Atm -/-mice express T cell receptors and exhibit only partial deficits in the size of their immature DP and mature SP thymocyte pools [8] [9] [10] [11] , indicating that ATM is not essential for recombination of TCRβ or TCRα loci.
V(D)J recombination is initiated by the lymphocyte-specific RAG-1/2 endonuclease, which generates DNA double strand breaks (DSB) in between recombination signal sequences and adjacent antigen receptor variable (V), diversity (D), or joining (J) gene segments 16 . The resulting coding ends (CE) and signal ends (SE) are repaired by the non-homologous end-joining (NHEJ) complex to make coding joins (CJ) and signal joins (SJ), respectively. Defective NHEJ causes abnormal accumulation of CE 17 and induction of p53-dependent apoptosis in thymocytes 18 . In NHEJ-p53 double mutant mice, defective DSB repair during IgH recombination causes frequent deletion of telomeric VH gene segments, facilitating generation of oncogenic translocations with cMyc and initiating IgH/cMyc amplification through repeated cycles of bridge-breakage-fusion [19] [20] [21] . Thus, defective NHEJ of RAG-induced DSB can promote lymphoid leukemogenesis.
Interestingly, ATM localizes to V(D)J recombination-induced DSBs 22 , suggesting that it may monitor recombination intermediates, thus limiting the oncogenic consequences of aberrant V(D)J recombination. Furthermore, two ATM substrates, H2AX and NBS1, also localize to V(D)J-induced DSBs and inactivating mutations in these proteins cause a phenotype reminiscent of ATM deficiency [23] [24] [25] . 
ATM loss compromises post-mitotic generation of TCRβ int DP and TCRβ hi SP thymocytes
The most striking consequence of ATM loss on T cell development is the reduction in TCRβ int DP thymocytes and their TCRβ hi progeny (Fig. 1 ). TCRβ int DP thymocytes are postmitotic, harbor in-frame TCRβ rearrangements and are actively recombining their TCRα loci 13 .
These cells are generated from precursors that cycle extensively during the DN3 to DP transition 32 . We reasoned that the reduction in Atm -/-TCRβ int DP thymocytes could reflect a defect in pre-TCR-induced clonal expansion of DN precursors, or reduced survival of postmitotic DP thymocytes. To distinguish between these alternatives, we monitored the initial generation and subsequent maturation of Atm -/-DP thymocytes 1-5 days after BrdU pulse labeling in vivo. As expected from previous reports 33 , most labeled wild-type cells were TCRβ low DP precursors 1 day post-BrdU injection, and their numbers decreased dramatically over the next 5 days, as they either died or matured into SP thymocytes ( Fig. 2A, B ). Similar proportions of the DN and DP subsets were labeled in Atm -/-and Atm +/+ controls on day 1, demonstrating that ATM loss did not affect thymocyte proliferation or the initial generation of TCRβ low DP thymocytes ( Fig. 2A, B) . Fig. 2 ). BrdU pulse-chase experiments showed that BCL-2 over-expression in Atm -/-mice failed to rescue post-mitotic production of TCRβ int DP thymocytes to wild-type levels (Fig. 3) . Based on these experiments we concluded that ATM loss does not compromise generation of TCRβ int DP thymocytes by activating a BCL-2-sensitive apoptotic pathway. Vβ17 gene while the latter contains the Vβ17 pseudogene, ψ17) 37 . For Vβ17, the arrow indicates a rearrangement that falls out of the normal CDR3 length distribution.
FIGURE 2. Impaired production of TCRβ
To exclude the possibility that robust pre-TCR-induced clonal expansion obscured a subtle defect in V(D)J recombination, we examined transcripts from the Vβ17 pseudogene which cannot produce a functional TCRβ chain in mice carrying the Vβ b haplotype (Fig. 4B, C ) 37 . Even in the absence of selection for in-frame transcripts, Vβ17 transcripts displayed CDR3 lengths that were similarly diverse in Atm -/-and control thymocytes (Fig. 4B) Fig. 3 ). In addition, the abundance of Jα50 and Jα49 SE or SJ was similar in the two Atm genotypes (Suppl. Fig. 3 ). These strategies have previously revealed profound impairment of proximal Jα rearrangement and accumulation of proximal Jα CE 40 in NHEJ-deficient mice. We did not find similar defects in the initiation or processing of proximal Jα recombination intermediates in Atm -/-thymocytes. Therefore, if ATM loss impairs NHEJ during TCRα recombination, it was not detected by these approaches.
Analysis of secondary TCRα recombination in Atm -/-thymocytes
We next examined whether secondary TCRα recombination is impaired in Atm -/-thymocytes by a Southern blot strategy predicated on the observation that secondary TCRα rearrangements cause deletion of 5' Jα segments proximal to the Vα cluster 13, 14 . Using probes specific for proximal 5', "middle" and distal 3' regions of the Jα cluster, we found equivalent deletion of the proximal and middle Jα chromosomal regions in Atm-deficient and wild-type thymocytes, consistent with a similar extent of secondary TCRα recombination (Fig. 6A) Tables 1,2 ; Suppl. Fig. 4 ). The signal distributions in thymocytes from individual mice are shown in Fig. 7 , and the pooled signal distributions from mutant compared to wild-type thymocytes are shown in thymocytes. Note that the V≤2 versus V>2 comparison revealed no statistically significant differences between the two genotypes.
One major difference was that compared to wild-type cells, fewer mutant thymocytes had 2 TCRαC signals per cell ( Fig. 7I ; P<1x 10 -6 , Table 1 ), and a greater number had >2 TCRαC signals per cell ( Fig. 7II ; P<1x 10 -6 , Table 1 ). We noted a second striking difference in the distribution of TCRαV signals between wild-type and mutant thymocytes (Fig. 7III, IV) . For each sample 100-200 nuclei were imaged and scored.
Distribution

Discussion
We have demonstrated that the paucity of mature SP thymocytes in Atm -/-mice reflects impaired TCRα expression and defective maturation of post-mitotic DP thymocytes.
Surprisingly, we found no impairment of TCRβ recombination or generation of a diverse primary TCRβ repertoire. Furthermore, ATM loss did not compromise proliferation or survival during the DN to DP transition, since BrDU pulse-chase studies showed that normal numbers of TCRβ low DP thymocytes were generated in response to pre-TCR signals. In contrast, the postmitotic generation of TCRβ int DP and TCRβ hi SP thymocytes was dramatically impaired, and this defect was not rescued by BCL-2 over-expression. However, defective generation of these populations correlated with a high frequency of large bi-allelic deletions encompassing the distal TCRαV region, as well as reduced TCRα mRNA and protein. Thus, our data suggest that, after exiting the cell cycle, many ATM-deficient DP thymocytes undergo aberrant TCRαV deletion and die, limiting the pool of TCRβ int DP thymocytes available for positive selection. Based on these findings, we propose that ATM is vital for maintenance of locus integrity during the extended developmental window of TCRα recombination.
There are several features that could explain why ATM deficiency disrupts TCRα rearrangement without obviously affecting TCRβ recombination. First, the TCRα locus is dispersed over a much larger chromosomal region than the TCRβ locus, and the TCRαV region alone covers nearly 1 megabase 30 . Such long-range recombination events might be more prone to disruption in the absence of ATM. In support of this notion, ATM deficiency also impairs classswitch recombination 42, 43 , another event involving rearrangements over long chromosomal distances. Second, the TCRδ locus, which rearranges during the DN stage of development, is contained within the TCRα locus on mouse chromosome 14 30 . Moreover, TCRα but not TCRβ gene segments can undergo repeated rounds of secondary recombination on the same chromosome 12, 44 . Thus, chromosome 14 must remain patent during many rounds of V(D)J recombination at two different developmental stages. Finally, signaling through TCRβ-containing pre-TCR complexes triggers robust clonal expansion during the DN to DP transition 32 , whereas TCRαβ signaling induces DP thymocytes to mature without proliferating 45 .
Thus, a reduced efficiency of TCRβ recombination in ATM-deficient DN thymocytes could be masked by proliferative expansion. Notably, one study reported that AT patients exhibit restricted peripheral TCR-Vβ repertoires and oligoclonal CDR3 regions 7 . The distinction between that study and the data reported here likely reflects differences between primary unselected and peripheral TCR-Vβ repertoires. Moreover, our ATM-deficient mice were housed in specific pathogen-free conditions, whereas AT patients suffer recurrent sino-pulmonary infections, which would likely skew an already limited peripheral TCR repertoire.
Despite normal generation of TCRβ-expressing DP precursors, the pool of post-mitotic TCRβ int DP thymocytes was dramatically reduced in Atm -/-mice. Surprisingly, although this reduction correlated with a striking reduction in TCRα expression, proximal Jα rearrangement and secondary Jα recombination were not obviously impaired in ATM-deficient thymocytes.
However, these approaches did not evaluate if these rearrangements contained normal Vα-Jα coding joints. Since our molecular cytogenetic analyses showed frequent bi-allelic deletion of the entire distal TCRαV gene cluster, it is possible that many of the Jα rearrangements detected by Southern blotting were aberrant. Collectively, these observations reveal that ATM plays a critical role in maintaining TCRα locus integrity during recombination.
Our conclusion accords with the observation that ATM localizes to RAG-induced DSB Several possibilities could account for this apparent discrepancy. First, in the cell line model, recombination was temporally synchronized and only one CE could be generated. In contrast, Jα recombination occurs asynchronously in vivo, and many different Jα CE can be generated across the locus. Indeed we observed normal frequencies of middle and distal Jα recombination events.
Thus, the concentration of particular Jα CE may be too low in primary ATM-deficient thymocytes to detect by Southern blotting. Moreover, the substrate CE were short-lived in pre-B cell lines 29 . This rapid degradation could make Jα CE very difficult to detect in asynchronous populations of ATM-deficient thymocytes.
We have previously shown that the abnormal accumulation of V(D)J DSBs in NHEJdeficient thymocytes activates the p53-mediated DNA damage response pathway 18 . Analyses of Atm;p53 double mutant mice have demonstrated that the p53 and ATM-dependent DNA damage response pathways are not entirely over-lapping [46] [47] [48] , and ATM loss can lead to induction of p53-dependent apoptosis 49 . Indeed, spontaneous apoptosis was enhanced in ATM-deficient thymocytes (Suppl. Fig. 2 hours apart) at day 0. Thymocytes were isolated 1-5 days post-injection and stained as described above. BrdU detection was performed using the BrdU Flow Kit per manufacturer's instructions (BD Biosciences).
